Cargando…

Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine

Vaccination with different vaccines has been implemented globally to counter the continuous COVID-19 pandemic. However, the vaccine-elicited antibodies have reduced efficiency against the highly mutated Omicron sub-variants. Previously, we developed a protein subunit COVID-19 vaccine called ZF2001,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Shuxin, Zheng, Yuxuan, Gao, Zhengrong, Duan, Minrun, Liu, Sheng, Du, Pan, Xu, XiaoYu, Xu, Kun, Zhao, Xin, Chai, Yan, Wang, Peiyi, Zhao, Qi, Gao, George F., Dai, Lianpan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382582/ https://www.ncbi.nlm.nih.gov/pubmed/37507370 http://dx.doi.org/10.1038/s41421-023-00585-5

Ejemplares similares

Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™
por: Xu, Senyu, et al.
Publicado: (2023)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
por: Duan, Minrun, et al.
Publicado: (2023)

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines
por: Li, Dedong, et al.
Publicado: (2023)

Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
por: Xu, Kun, et al.
Publicado: (2022)

Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7
por: Zhang, Yanfang, et al.
Publicado: (2023)

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
por: Chen, Qian, et al.
Publicado: (2023)

mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2
por: Han, Yuxuan, et al.
Publicado: (2022)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
por: Shi, Juan, et al.
Publicado: (2023)

Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice
por: Tian, Siyu, et al.
Publicado: (2021)

Antibody engineering for increased potency, breadth and half-life
por: Sievers, Stuart A., et al.
Publicado: (2015)

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)

The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
por: Tolbert, William D., et al.
Publicado: (2023)

A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
por: An, Yaling, et al.
Publicado: (2022)

Diet Breadth Mediates the Prey Specificity of Venom Potency in Snakes
por: Lyons, Keith, et al.
Publicado: (2020)

Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost
por: Nair, Manoj S., et al.
Publicado: (2023)

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
por: Pan, Xiaoyan, et al.
Publicado: (2021)

Finite neutralisation breadth of omicron after repeated vaccination
por: Zhu, Yufang, et al.
Publicado: (2022)

Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
por: Chen, Ying, et al.
Publicado: (2023)

Partial germline reversions can increase VRC07 potency and breadth
por: Rudicell, RS, et al.
Publicado: (2012)

The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
por: Yang, Jingyi, et al.
Publicado: (2023)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Omicron’s message on vaccines: Boosting begets breadth
por: Wesemann, Duane R.
Publicado: (2022)

Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
por: Dai, Lianpan, et al.
Publicado: (2022)

COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
por: Liang, Hong, et al.
Publicado: (2022)

Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles
por: Zhang, Peng, et al.
Publicado: (2023)

Dynamics of thymus function and T cell receptor repertoire breadth in health and disease
por: Granadier, David, et al.
Publicado: (2021)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

Viral targets for vaccines against COVID-19
por: Dai, Lianpan, et al.
Publicado: (2020)

Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination
por: Roth, Gillie A., et al.
Publicado: (2021)

Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
por: Mantus, Grace, et al.
Publicado: (2022)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency
por: Shen, Chenguang, et al.
Publicado: (2019)

Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBD
por: Ventura, Cathy, et al.
Publicado: (2022)

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
por: Roskin, Krishna M., et al.
Publicado: (2020)

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
por: Yang, Shilong, et al.
Publicado: (2021)

Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
por: Peng, Hua, et al.
Publicado: (2022)

A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
por: Qu, Qiaoqiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uic9ckdi7djigpa0tah52oeda9